Insilico Medicine Cayman Topco (ISLMF)

$4.93 -1.03 (-17.23%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 37,600
Avg Vol 3,776
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 91%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology, metabolic, anti-pain, and other therapeutic areas. The company is also involved...

Address:
Building 8W, Phase 2, Unit 310, 3/F Hong Kong Science Park Pak Shek Kok, Hong Kong, Hong Kong
Markus_Montag
Markus_Montag Mar. 16 at 9:36 PM
$RXRX I hear lots of good things about AI for drug discovery. Why is this stock so low? I believe it is the leader in the space but others trade way better $GENB and $ISLMF
1 · Reply
Latest News on ISLMF
No data available.
Markus_Montag
Markus_Montag Mar. 16 at 9:36 PM
$RXRX I hear lots of good things about AI for drug discovery. Why is this stock so low? I believe it is the leader in the space but others trade way better $GENB and $ISLMF
1 · Reply